Scholar Rock Shares Rise 9.1% After FDA Approves ISEMBYLD for Spinal Muscular Atrophy
Scholar Rock Holding Corp (NASDAQ:SRRK) shares rose 9. 1% in pre-market trading to $60.
Search
Search covers the most recently published. For the full archive, browsethe topics.
1 result for"Scholar Rock"